Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam
CONCLUSIONS: In the three countries evaluated, total treatment costs with regular twice-daily FP/salm were consistently lower than with budesonide/formoterol MART due to lower direct healthcare costs.PMID:33764239 | DOI:10.1080/02770903.2021.1903915
Source: Journal of Asthma - Category: Respiratory Medicine Authors: Bhumika Aggarwal Paul W Jones Faisal Yunus Le Thi Tuyet Lan Watchara Boonsawat Afisi Ismaila Sibel Ascioglu Source Type: research
More News: Advair | Advair Diskus | Asthma | AstraZeneca | Corticosteroid Therapy | Flonase | Flovent | Healthcare Costs | Indonesia Health | Respiratory Medicine | Statistics | Study | Symbicort | Thailand Health | UK Health | Vietnam Health